The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells (original) (raw)
Interleukin-6 Production by Bladder Tumors is Upregulated by BCG Immunotherapy
Kesavan Esuvaranathan
The Journal of Urology, 1995
View PDFchevron_right
Can The Systemic Immune Inflammation Index Be A Predictor Of BCG Response In Patients With High-Risk Non-Muscle Invasive Bladder Cancer?
Hasan Tavukçu
2020
View PDFchevron_right
Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells
Harald Lahm
Cancer Letters, 2000
View PDFchevron_right
Interleukin-6: Effects on Tumor Models in Mice and on the Cellular Regulation of Transcription Factor IRF-1a
Sheila Harroch
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Mechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells
Ke-hung Tsui
2013
View PDFchevron_right
Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population
Priyanka Srivastava
Gene, 2013
View PDFchevron_right
{"__content__"=>"BCG-induced cytokine release in bladder cancer cells is regulated by Ca signaling.", "sup"=>{"__content__"=>"2+"}}
Abolfazl Hosseini
Molecular oncology, 2018
View PDFchevron_right
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Tzafra Cohen
Journal of Biological Chemistry, 1996
View PDFchevron_right
CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
irene otero
Clinical Cancer Research, 2018
View PDFchevron_right
Does the Urinary Mast Cell Mediators Predict the Immune Response to BCG in Patients with Primary High-Grade Non-Muscle Invasive Bladder Cancer?
Bulent Onal
Authorea (Authorea), 2020
View PDFchevron_right
BCG Infection after Bladder Cancer Treatment—3 Clinical Case Reports
Angélica Ramos
Advances in Infectious Diseases, 2015
View PDFchevron_right
Systemic Interleukin-6 Response after Intravesical Instillation of Bacillus Calmette-Guérin and Mitomycin C in Superficial Bladder Cancer
Archives of Razi Institute Journal
View PDFchevron_right
Inflammation in prostate carcinogenesis
Angelo Marzo
Nature Reviews Cancer, 2007
View PDFchevron_right
A Functional Polymorphism in RGS6 Modulates the Risk of Bladder Cancer
Lance Liotta
Cancer Research, 2004
View PDFchevron_right
Pathways connecting inflammation and cancer
Cecilia Garlanda
Current Opinion in Genetics & Development, 2008
View PDFchevron_right
Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer
Mahmoud Elrouby
Asian Pacific Journal of Cancer Prevention, 2015
View PDFchevron_right
Identification of Genes Correlated with Early-Stage Bladder Cancer Progression
Raja loganantharaj
Cancer Prevention Research, 2010
View PDFchevron_right
Regulation of ? 2 -Macroglobulin Gene Expression by Interleukin-6
Peter Heinrich
Annals of the New York Academy of Sciences, 1994
View PDFchevron_right
Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients
Syah Warli
World Journal of Oncology
View PDFchevron_right
PAX8 expression in human bladder cancer
Francesca Saro
Oncology Reports, 2006
View PDFchevron_right
Association between −174 G/C Promoter Polymorphism of the Interleukin-6 Gene and Progression of Prostate Cancer in North Indian Population
Ram Sagar
DNA and Cell Biology, 2008
View PDFchevron_right
Cell Cycle Checkpoint Function in Bladder Cancer
Stephanie McKeown
JNCI Journal of the National Cancer Institute, 2003
View PDFchevron_right
Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent
Frederick A Moore
Journal of Leukocyte Biology, 1995
View PDFchevron_right
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Mario Taffurelli, Paola Paterini
Journal of Clinical Investigation, 2007
View PDFchevron_right
Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio
Tommaso Cai
Experimental and therapeutic medicine, 2012
View PDFchevron_right
Immunohistochemical Expression of Ki67 Antigen, Cox2 and Bax/Bcl2 in Prostate Cancer; Prognostic Value in Biopsies and Radical Prostatectomy Specimens
David Ramos
European Urology, 2005
View PDFchevron_right
Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
Maria Mudryj
Biomedicines, 2021
View PDFchevron_right
Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer
Raphael Saginur
International Urology and Nephrology, 1998
View PDFchevron_right
Failure of Bacillus Calmette Guerin (BCG) therapy for the treatment of bladder cancer: Al-Azhar experience
mohamed elmalah
African Journal of Urology, 2009
View PDFchevron_right
Chapter 18 Inflammatory Microenvironment in Prostate Carcinogenesis
Elba Vazquez
2018
View PDFchevron_right
BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation
Simon Wagner
Oncogene, 2003
View PDFchevron_right
Inflammatory Microenvironment in Prostate Carcinogenesis
Elba Vazquez
Advances in Prostate Cancer, 2013
View PDFchevron_right
Interleukin-24 is correlated with differentiation and lymph node numbers in rectal cancer
choi youngmin
World Journal of Gastroenterology, 2011
View PDFchevron_right
Prostate carcinogenesis and inflammation: emerging insights
Angelo Marzo
Carcinogenesis, 2004
View PDFchevron_right
Interleukin-6 and the IL-6 (–174) C/G polymorphism in breast pathologies and in HIV-infected patients
Elzbieta Jablonowska
Archives of Medical Science, 2010
View PDFchevron_right